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Adeno-associated virus (AAV) and the other parvoviruses have long been known to inhibit proliferation of nonpermissive
cells. The mechanism of this inhibition is not thoroughly understood. To learn how AAV interacts with host cells, we have
begun an investigation into AAV’s relationship with adenovirus (Ad), AAV’s most efficient helper virus. AAV, but not
UV-inactivated AAV, delayed Ad-induced cytotoxicity and inhibited Ad E2a gene expression. AAV, but not UV-inactivated AAV
or a recombinant AAV vector, inhibited Ad DNA replication. To determine whether AAV or its replication (Rep) proteins alter
Ad early gene expression, we measured steady state E2a mRNA levels in AAV and Ad coinfected cultures and in a cell line
(Neo6) that inducibly expresses the Rep proteins. AAV, but not UV-AAV, and Rep expression resulted in diminution of E2a
protein and mRNA levels. To determine whether the AAV Rep proteins directly affect the individual Ad early promoters, we
constructed luciferase reporter plasmids containing each of the five early promoters. Cotransfection of Ad-luciferase and an
AAV rep gene-expressing plasmid in HeLa cells demonstrated that Rep78 repressed the E1a, E2a, and E4 promoters but
trans-activated the E1b and E3 promoters. In the presence of a cotransfected E1a-expressing plasmid, Rep78 repressed
expression from all five promoters. These results indicate that Rep may have different effects on the Ad early promoters
dependent upon the presence of the E1a trans-activating protein. © 2001 Elsevier Science
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Adeno-associated virus (AAV) is classified in the De-
pendovirus genus of the family Parvoviridae because it
normally depends on the assistance of a helper virus to
efficiently complete its replication cycle (reviewed in
Berns and Giraud, 1996). Adenovirus (Ad) is the most
efficient helper for AAV, although human papillomavirus
(HPV) (Ogston et al., 2000; Walz et al., 1997), cytomega-
lovirus, vaccinia virus, Epstein–Barr virus, and herpes
virus will also support variable levels of AAV replication
(Atchison, 1970; Dolin and Rabson, 1973; Buller et al.,
1981; McPherson et al., 1985). AAV replicates in the
absence of helper virus infection when cultured cells
have been synchronized or challenged with DNA-dam-
aging agents (Yakobson et al., 1987, 1989). Recently it has
been suggested that AAV replicates autonomously in
differentiating keratinocytes (Meyers et al., 2000). In the
absence of a helper virus coinfection, AAV integrates into
the long arm of chromosome 19 (reviewed in Chiorini et
al., 1996). The provirus remains at this locus until the host
cell is infected with a helper virus and subsequently
“rescues” the provirus, thus initiating the replication cy-
cle.
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140Although AAV has never been conclusively linked to
any disease or pathogenic condition, the virus exerts
profound effects on the replication of its helper virus and
the infected cell. In a helper virus free environment, AAV
infection of cells alters the expression of several cell
cycle regulated genes (Hermanns et al., 1997), promotes
differentiation-like effects (Klein-Bauerschmitt et al.,
1992; Winocour et al., 1992), and induces a late S-phase
and/or G2-phase cell cycle block (Winocour et al., 1988).
AAV infection of primary human cells induces a cell cycle
block that is correlated with a decrease in retinoblas-
toma (Rb) protein phosphorylation and an increase in
p21Cip gene expression (Hermanns et al., 1997). Retrovi-
rus vectors expressing AAV replication proteins induced
G1 and G2 cell cycle arrest (Saudan et al., 2000).
AAV also exerts inhibitory effects on the Ad helper
virus in coinfected cells. AAV, but not defective interfering
(DI) particles, blocks Ad DNA replication (Carter et al.,
1979; Casto et al., 1967a,b; Laughlin et al., 1979). These
results suggest that AAV gene expression or amplifica-
tion of the AAV genome may be essential for Ad inhibi-
tion. AAV also inhibits Ad-induced transformation (re-
viewed in Carter, 1990). Inhibition of Ad-induced tumori-
genicity and cellular transformation has been attributed
to the AAV terminal repeat sequences and AAV genes
(de la Maza and Carter, 1981; Khleif et al., 1991), whereas
the effects on Ad replication have been attributed to
141INHIBITION BY ADENO-ASSOCIATED VIRUSexpression of the AAV replication (rep) gene (Weitzman
et al., 1996).
The AAV rep gene encodes four replication proteins:
Rep78, Rep68, Rep52, and Rep40. Rep78 and Rep68 are
pleiotropic modulators of the AAV replication cycle reg-
ulating viral gene expression, DNA replication, site-spe-
cific integration into the chromosome 19 locus, and cel-
lular gene expression. In viral DNA replication they bind
to a 16-bp Rep binding site (RBS) found in the A-stem of
the covalently closed end of the AAV origin of replication.
Upon binding, either of the larger Rep proteins will make
a site-specific strand-specific cut at a terminal resolution
site (trs) 17 nucleotides from the RBS (Im and Muzyczka,
1990; Snyder et al., 1990). This cleavage results in cova-
lent attachment of the Rep protein to the 59 end of the
viral DNA (Snyder et al., 1990; Prasad and Trempe, 1995;
Prasad et al., 1997). In the absence of helper virus, Rep78
or Rep68 will bind and cleave the cellular RBS found in
the chromosome 19 integration site to mediate viral DNA
integration (Urcelay et al., 1995). In addition to DNA
replication and integration, the Rep proteins regulate
viral gene expression. Rep78 and Rep68 repress tran-
scription from the p5 promoter in the presence and
absence of Ad coinfections (Beaton et al., 1989; Kyostio
et al., 1995; Pereira et al., 1997). In the presence of Ad
coinfection, Rep78 and Rep68 activate transcription of
the p19 and p40 promoters (McCarty et al., 1991; Pereira
et al., 1997). Rep78 or Rep68 have also been reported to
block translation of cap gene mRNA (Trempe and Carter,
1988).
Transient expression of the rep gene prevents cellular
DNA replication, which may be caused by inhibition of
cell cycle progression or a direct effect on DNA synthe-
sis (Yang et al., 1994, 1995; Saudan et al., 2000). Two
different cell lines have been established that express
the rep gene under the control of inducible transcription
promoters (Yang et al., 1994; Holscher et al., 1994). Both
cell lines express Rep proteins that retain wild-type func-
tions. However one of the cell lines arrests in S-phase
upon induction of Rep expression (Yang et al., 1994). The
rep gene has also been shown to inhibit human herpes-
virus (Kleinschmidt et al., 1995), HIV (Antoni et al., 1991;
Ritter et al., 1992), SV40 (Bantel-Schaal and ZurHausen,
1988; Yang et al., 1995), and bovine papillomavirus rep-
lication (Hermonat, 1992). In a variety of plasmid cotrans-
fection studies, rep gene expression inhibits gene ex-
pression from some heterologous promoters (Antoni et
al., 1991; Horer et al., 1995; Khleif et al., 1991; Labow et
al., 1987) and increases expression from the c-sis gene
promoter (Wonderling and Owens, 1996) and the CMV
early promoter (Wonderling et al., 1997).
We have begun a study of the relationship between
AAV and Ad as a model system for understanding AAV
and host–cell interactions. We present evidence that AAV
and its encoded Rep proteins inhibit Ad replication and
that these inhibitions are due, in part, to inhibition of E2agene expression. The Rep protein-mediated alterations
on Ad gene expression are due to effects on Ad early
gene promoters as well as on E1a-mediated trans-acti-
vation of early gene expression.
RESULTS
AAV inhibits Ad-induced cytotoxicity
Ad-infected cells develop cytopathic effects (CPE)
characterized by progressive deterioration of cell viability
and eventual cell death. To determine whether AAV coin-
fection affects Ad-mediated CPE, HeLa cells were coin-
fected with Ad (multiplicity of infection (m.o.i.) 5 5) and
either AAV or UV-inactivated AAV (m.o.i. 5 400). Twenty-
four hours after infection and at every 24 h thereafter,
viability assays were performed. Trypan blue counting of
the percentage of viable cells showed that a decrease in
viability for the Ad-infected cultures is first noticeable
after the 72-h time point (Fig. 1A). By 96 h, the Ad-infected
or the Ad- and UV-AAV-coinfected cultures were approx-
imately 50% viable. In contrast, the 50% viability level for
the AAV- and Ad-coinfected cultures was not reached
until approximately 132 h after infection.
The AAV-mediated delay of Ad cytotoxicity was verified
in a similar assay in which viability was measured with
an MTT assay. A decrease in cell viability was observed
after the 72-h time point for both the Ad and the Ad plus
UV-AAV coinfected cultures (Fig. 1B). However the Ad
and AAV coinfected cultures continued to grow until the
96-h time point after which the cells began to die. These
results support the conclusion that AAV, but not UV-
inactivated AAV, delayed Ad-mediated cytotoxicity.
UV-AAV competes with normal AAV for virus receptor
binding
Cellular AAV uptake has been proposed to occur via
virus binding to a receptor composed of a heparin sulfate
proteoglycan (Summerford and Samulski, 1998) and pos-
sibly the fibroblast growth factor receptor (Qing et al.,
1999). Integrin aVb5 is also involved in virus internaliza-
tion (Summerford et al., 1999). One possible explanation
for the different effects of AAV and UV-AAV in the toxicity
assays is that UV irradiation damaged the virion, pre-
venting it from binding to its receptor. To determine
whether UV-AAV competes with normal particles for re-
ceptor binding, Ad-infected HeLa cells were transduced
with an AAV-bgal vector at an m.o.i. of 1, and two different
amounts of an AAV-gfp (gfp, green fluorescent protein)
vector that was either UV-inactivated or left untreated.
Figure 2 shows that in the presence of either the AAV-gfp
or the UV-inactivated AAV-gfp vector, there was approx-
imately a 2.5-fold decrease in AAV-bgal transduction.
Both the untreated and the UV-irradiated AAV-gfp vector
inhibited transduction at similar levels. The level of com-
petition for the AAV receptor was comparable to that
142 JING ET AL.observed in the presence of 1 mM heparin, which effec-
tively prevents AAV binding (Summerford and Samulski,
1998). This indirect evidence suggests that UV treatment
does not affect virus binding to its receptor.
AAV-mediated inhibition of Ad DNA replication
AAV-mediated inhibition of Ad infection is both time
and dose dependent (Carter et al., 1979; Casto et al.,
1967a,b). If Ad infection precedes AAV infection by more
than 4 h, AAV does not block Ad replication. Alternatively,
if AAV infection accompanies or precedes Ad infection,
then Ad replication is blocked in an AAV dose-dependent
FIG. 1. AAV inhibition of Ad cytotoxicity. (A) HeLa cells were plated in
24-well dishes in triplicate. The cultures were infected with Ad5 (m.o.i.
5 5) alone or together with AAV or UV-inactivated AAV (m.o.i. 5 400).
The inoculum was removed, replaced with fresh serum-containing
medium, and incubated at 37°C for the duration of the experiment.
Twenty-four hours after infection and every 24 h thereafter, the cultures
were harvested and counted as described in the text. (B) HeLa cells in
phenol red-free MEM were plated in 24-well dishes in triplicate. The
cultures were infected with Ad5 and AAV or UV-inactivated AAV.
Twenty-four hours after infection and every 24 h thereafter, MTT viabil-
ity assays were performed as described in the text. OD 595 refers to the
amount of absorbance at 595 nm.manner. To verify that Ad replication is inhibited during
the course of an AAV coinfection, human KB cells wereinfected with AAV, or UV-inactivated AAV, 5 h prior to Ad
infection. Twenty-four hours after Ad infection the cul-
tures were harvested and viral DNA isolated. The Ad
DNA was digested with EcoRI, separated by agarose gel
electrophoresis, and probed with radioactively labeled
Ad DNA. Ad replication in the presence of two different
concentrations of AAV was substantially inhibited (com-
pare lane 1 to lanes 3 and 4, Fig. 3). However UV-
inactivated AAV was unable to block Ad replication (com-
pare lane 1 to lanes 5 and 6, Fig. 3).
Similar experiments were performed using a recombi-
nant AAV vector (AAV-bgal) that lacks rep and cap genes
(Table 1). HeLa cells were coinfected with Ad5 (m.o.i. 5
1) and different amounts of AAV, UV-AAV, or AAV-bgal. Ad
DNA replication was analyzed by Southern hybridization
as described above and the results were measured by
densitometer analysis. In Table 1 we see that AAV, but
not UV-AAV or AAV-bgal, inhibited Ad DNA replication in
HeLa cells (expts 1 and 2). It is interesting to note also
that Ad replication in the presence of UV-AAV or AAV-
bgal is apparently more abundant than in the absence of
any AAV. The results shown in Fig. 3 and Table 1 suggest
that amplification of AAV or expression of the AAV ge-
nome is required for inhibition of Ad replication. These
results also indicate that the virion is not sufficient for
inhibition of Ad replication.
FIG. 2. UV-inactivated AAV competes with normal virus for receptor
binding. HeLa cells in 24-well dishes were transduced with 1 m.o.i. of
AAV-bgal (bgal) alone, or along with 5 or 25 m.o.i. of AAV-gfp (GFP) or
UV-inactivated AAV-gfp (GFP-UV). One hour after adding the vector, the
cell monolayer was removed and washed with PBS. Normal medium
containing Ad5 at an m.o.i. of 5 was placed on the cultures for 48 h.
Alternatively 1 mM heparin was used in place of the AAV-gfp vector to
block AAV binding to its receptor. b-Galactosidase assays were per-
formed 48 h after transduction. Results are from triplicate assays and
are reported as relative light units (RLU) per microgram of protein.
samples from AAV, UV-AAV, or AAV-bgal coinfected cultures is reported
as a fraction of the Ad replication level.
143INHIBITION BY ADENO-ASSOCIATED VIRUSAAV and Rep protein expression inhibit Ad E1A and
E2A protein expression
AAV-mediated inhibition of Ad DNA replication may be
due to several possible mechanisms. AAV or its gene
products may directly inhibit Ad DNA replication by com-
peting with the Ad genome for limited replication factors.
Alternatively, Ad early gene expression may be inhibited
such that viral DNA replication is prevented. Immunoblot
analyses were performed to determine whether Ad early
gene expression is affected by AAV infection. HeLa cells
were infected with two different m.o.i. of AAV and Ad.
Forty-eight hours later the cultures were harvested and
analyzed by SDS–PAGE and immunoblotting. In Fig. 4A it
is apparent that AAV has a dose-dependent effect on
expression of the Ad E2a and E1a gene products. When
a similar experiment was performed using normal and
UV-AAV, comparable results were obtained (Fig. 4B). AAV
Rep protein expression was observed in the AAV-in-
fected cultures (Fig. 4B). As seen in Fig. 4, the AAV-
mediated inhibition of E2a expression is variable and
dose dependent. Comparison of E2a expression from
four independent infections revealed that at an AAV m.o.i.
of $100, the E2a level in an AAV coinfection was 33% of
the level of E2a expression in UV-AAV coinfections. When
the AAV m.o.i. was decreased to $10, the E2a expres-
sion level in AAV coinfection was 49% of the level ob-
served in UV-AAV coinfection (data not shown). These
results indicate that AAV coinfection results in inhibition
of Ad early gene expression and that this inhibition is
correlated with AAV Rep protein expression.
To determine whether Rep protein expression alone is
FIG. 3. AAV inhibition of Ad replication. KB cells (1 3 106) were
infected with AAV 5 h before infection with Ad type 2. Forty-eight hours
after infection cultures were harvested, viral DNA isolated, digested
with EcoRI, separated by agarose gel electrophoresis, and submitted to
Southern hybridization with a radiolabeled Ad probe. Every lane con-
tains extracts from cells infected with Ad at an m.o.i. of 5, whereas
lanes 3–6 also contain AAV. Lane 1, Ad alone; lane 2, input Ad after 2 h
of adsorption; lane 3, AAV, m.o.i. of 50; lane 4, AAV m.o.i. of 250; lane 5,
UV-inactivated AAV, m.o.i. of 50; lane 6, UV-inactivated AAV, m.o.i. of 250;
lane 7, input Ad (as in lane 2). The locations of the restriction fragments
are indicated by letters on the side of the figure.sufficient for inhibition of Ad early gene expression, sim-
ilar experiments were performed in a cell line (Neo6) thatTABLE 1
Ad DNA Replication in AAV-Infected Culturesa
Expt 1b Expt 2b Expt 3b
Ad alone 1.00 1.00 1.00
AAV 1 1.50 0.72 —
AAV 10 — 0.56 —
AAV 50 — — 0.07
AAV 100 0.46 0.52 —
AAV 250 — — 0.48
UV-AAV 1 2.71 1.47 —
UV-AAV 10 — 1.30 —
UV-AAV 50 — — 1.33
UV-AAV 100 3.24 1.18 —
UV-AAV 250 — — 0.96
AAV-bgal 1 1.89 1.23 —
AAV-bgal 10 — 1.54 —
AAV-bgal 100 0.96 1.22 —
a HeLa cells (expts 1 and 2) or KB cells (expt 3) were infected with
1 m.o.i. of Ad5 (expts 1 and 2) or 5 m.o.i. of Ad2 (expt 3). AAV, UV-AAV,
or AAV-bgal were used to coinfect the cultures at the m.o.i. indicated to
the right of the virus used. Viral DNA was analyzed by Southern
hybridization analyses 48 h later. The resulting autoradiograms were
submitted to densitometer analyses in which one or more of the bands
on the film were analyzed. For example, in Expt 3 (see also Fig. 3) band
“F” was analyzed. A dash (—) means that the indicated m.o.i. was not
used in the experiment. Each experiment was performed with different
lots of AAV, Ad, and AAV-bgal.
b The levels of replication of the Ad alone samples in each experi-
ment were set as 1.0. The amount of Ad replication of each of theFIG. 4. AAV inhibition of Ad early gene expression. (A) HeLa cells
were infected with AAV at an m.o.i. of 20 and 200, and Ad at an m.o.i.
of 1 or 5. Forty-eight hours later the cultures were harvested, cellular
extracts prepared, proteins separated by SDS–PAGE, and analyzed by
immunoblotting using anti-E1a and anti-E2a antibodies. The lanes
indicated with a dash came from cultures that were not AAV-infected.
(B) HeLa cells were infected with AAV or UV-inactivated AAV at an m.o.i.
of 20 and 400 as described above. Ad infection was at an m.o.i. of 1.
Forty-eight hours later the cultures were harvested and viral proteins
analyzed as described above using anti-E1a, anti-E2a, and anti-Rep
antibodies. The locations of the E2a, E1a, and Rep proteins are indi-
cated at the right of the figure.
144 JING ET AL.inducibly expresses Rep proteins. Neo6 cells were de-
rived from Ad E1a- and E1b-transformed 293 cells (Yang
et al., 1994). These cells express a fully functional AAV
rep gene under the control of a mouse metallothionein
transcription promoter but lack all other viral elements.
Rep protein expression is inducible in these cells by the
addition of heavy metal salts to the culture medium.
Neo5 cells, which do not express Rep proteins, were
used as a control in these experiments. Rep expression
was induced 7–10 h before Ad infection and the cultures
were harvested 48 h after virus adsorption. Immunoblot
analyses of infected Neo5 and Neo6 cells were then
used to detect E1a and E2a protein expression. In Fig. 5A
we see that induction of Rep in Neo6 cells results in
inhibition of E2a expression. This inhibition is not ob-
served in the control Neo5 cells. Unlike the results
shown in Fig. 4, E1a levels are not affected by heavy
metal induction in this experiment. The 293 cell-derived
Neo5 and Neo6 cells carry an endogenous copy of 11%
of the left end of the Ad5 genome (Graham et al., 1977).
Presumably, the E1a proteins detected in Fig. 5A ema-
nate from the infecting viral genome as well as from the
endogenous copy of the E1a gene. To determine whether
the induced Rep protein in Neo6 cells affects the expres-
sion of the endogenous E1a gene, Neo5 and Neo 6 cells
were induced for 40 h and then analyzed by immuno-
blots. Figure 5B shows that neither the heavy metal salts
FIG. 5. AAV Rep-mediated inhibition of Ad E2a gene expression. (A)
The AAV Rep protein-expressing Neo6 and control Neo5 cells were
treated with heavy metal salts (HM) for 16 h prior to infection with Ad
at an m.o.i. of 1. Forty-eight hours later the cultures were harvested,
protein extracts prepared, separated by SDS–PAGE, and immunoblot-
ted using anti-Rep, anti-E1a, and anti-E2a antibodies. (B) Neo5 and
Neo6 cells were left untreated (2) or were induced (1) for 40 h. The
cultures were harvested, protein extracts prepared, separated by SDS–
PAGE, and immunoblotted using anti-Rep and anti-E1a. The locations
of E1a and Rep78 are indicated. The band labeled by an asterisk is a
cellular, cross-reacting band detected by the Rep antibody (Trempe et
al., 1987).nor Rep expression alters E1a expression in Neo5 or
Neo6 cells. These results, combined with those shown inFig. 4, suggest that AAV or Rep expression is able to
suppress E1a expression from within the context of the
Ad chromosome but not from the context of the cellular
chromosome.
AAV and Rep expression inhibit Ad E2a mRNA
accumulation
The AAV Rep proteins have been reported to have
effects on mRNA accumulation from several viral and
cellular genes. AAV rep gene expression has also been
reported to affect protein translation (Trempe and Carter,
1988; Takeuchi et al., 2000). To determine whether the
AAV and Rep effects on Ad E2a gene expression result
from transcriptional or posttranscriptional events, we an-
alyzed the steady state levels of E2a mRNA in HeLa cells
coinfected with Ad and AAV, and in Neo5/6 cells infected
with Ad. In the experiments shown in Figs. 4 and 5, Ad
E2a expression was analyzed by immunoblot analyses
up to 48 h after infection. Therefore it was not possible to
determine whether the lower levels of E2A proteins re-
sulted from AAV- and Rep-mediated inhibition of gene
expression or prevention of Ad genome replication. Am-
plification of the Ad genome would result in fewer tran-
scription templates and lower protein levels. To deter-
mine whether AAV and Rep expression had direct effects
on early gene expression, we artificially prolonged the
early phase of Ad infection. DNA synthesis inhibitors
have been used to prolong the early phase of Ad infec-
tion and prevent the early-to-late transition in the Ad
replication cycle (Wilson et al., 1979; reviewed in Horwitz,
1990). This allows for accumulation of early gene mRNAs
that are then more easily detected by Northern analyses.
HeLa cells were coinfected with Ad and AAV or UV-AAV,
in the presence and absence of 10 mM hydroxyurea
(HU). Forty-eight hours later the cultures were harvested
and total RNA isolated. The RNA was separated by
agarose electrophoresis and analyzed by Northern hy-
bridizations using radioactively labeled E2a or actin gene
probes. In the presence of normal AAV there was a two-
to threefold decrease in the level of E2a mRNA levels
compared to UV-AAV treated or untreated Ad-infected
HeLa cells (Fig. 6A). In a parallel set of cultures, HU was
added to the culture medium 5 h after Ad adsorption. As
occurred in the absence of HU, E2a mRNA was dimin-
ished two- to threefold in the presence of normal AAV
compared to UV-AAV. Equal loading of RNA was verified
by comparable levels of actin mRNA. Similar analyses of
E2a mRNA levels were performed on Ad-infected Neo5/6
cells (Fig. 6B). It was evident that Rep expression pre-
vented E2a mRNA accumulation when Ad replication
was blocked by HU or in the absence of the drug. These
results suggest that in the absence of AAV and Ad
amplification, AAV infection and Rep expression inhibits
E2a gene expression. That the Rep protein from AAV is
capable of blocking Ad early gene expression in HU-
145INHIBITION BY ADENO-ASSOCIATED VIRUStreated, doubly infected cells is supported by the results
from the Neo6 cell experiments.
AAV Rep78 protein alters gene expression from Ad
early transcription promoters
The E1a gene is the first viral gene to be expressed in
an Ad infection. The products of the E1a gene have
wide-ranging effects on cellular and Ad gene expression
(reviewed in Flint and Shenk, 1997). The 13S mRNA-
encoded, 289 amino acid (a.a.) E1a protein stimulates Ad
gene expression by trans-activating the Ad transcription
promoters. These trans-activating effects are mediated
primarily by conserved region 3 (CR3), which is found
only in the 289 a.a. protein. From our virus infection
experiments it is clear that AAV and the Rep proteins
inhibit Ad early gene expression. Rep protein effects may
be due to direct action on the Ad promoters or to an
inhibition of E1a’s ability to trans-activate the Ad promot-
ers. To determine which of these possibilities occurs, we
amplified the transcription promoters of the five Ad early
genes using PCR and linked them to a luciferase reporter
gene. Each of the Ad/luc plasmids was then transfected
into HeLa cells along with a Rep78-expressing plasmid
(pCDMRep78) or control plasmid (pCDM8). Reporter
gene expression from the E1a, E2a, and E4 promoters
was suppressed in the presence of the wild-type form of
the rep gene (Fig. 7A). The effects on the E2a promoter
FIG. 6. Northern analysis of E2a mRNA after AAV infection and Rep
expression. (A) HeLa cells were infected with Ad and AAV or UV-
inactivated AAV. At 5 h after infection, HU was added to the culture
medium. Forty-eight hours after Ad infection the cultures were har-
vested, total RNA was isolated, separated by formaldehyde agarose gel
electrophoresis, transferred to filter membranes, and hybridized to
radiolabeled actin or E2a gene probes. (B) Neo5 and Neo6 cells were
treated with heavy metal salts (HM) for 16 h. The cultures were then
infected with Ad. Forty-eight hours later RNA was prepared and ana-
lyzed by Northern hybridization as described above. A “1” sign indi-
cates the presence of Ad or AAV. A “uv” indicates the use of UV-
inactivated AAV.were the most variable of the three suppressed promot-
ers in that Rep-mediated suppression ranged from al-most no suppression to slightly over twofold as shown
here. For the E1b and E3 promoters we consistently
observed Rep-mediated trans-activation.
To determine whether Rep affected the E1a protein’s
ability to trans-activate the Ad early promoters, a similar
series of luciferase assays were performed using a plas-
mid that expresses the 289 a.a. E1a protein (White et al.,
1991). To ensure that there were equivalent amounts of
E1a protein expressed in cotransfections with pCDM8
and pCDMRep78, preliminary transfections and immu-
noblot analyses were performed. These experiments
showed that when the E1a-expressing plasmid was
transfected in a 2:1 ratio over the Rep plasmids, there
was no difference between the two cotransfections in the
level of expressed E1a protein (results not shown).
Therefore the E1a, Rep, and Ad/luc plasmids were trans-
fected onto HeLa cells in a 2:1:0.5 mg ratio, respectively.
Forty-eight hours later luciferase assays were per-
formed. As expected, the presence of the 289 a.a. E1a
protein resulted in substantially more luciferase activity.
However, Rep78 was found to inhibit expression from all
FIG. 7. AAV Rep effects on Ad early promoters. (A) HeLa cells were
cotransfected with plasmids containing the individual Ad early promot-
ers driving the luc gene and either a wild-type rep gene expressing
plasmid, pCDMRep78 (striped box), or the cloning vector pCDM8 (solid
box). Forty-eight hours after transfection the cultures were harvested,
cell extracts prepared, and luciferase enzyme activity was determined.
The enzyme activity in relative light units (RLU) was reported as a
function of total protein. These results are derived from triplicate as-
says and are representative of four different transfection experiments.
(B) HeLa cells were transfected with the Ad-luc plasmids, the rep gene
plasmids, and pCMVE1a13S. The results are reported as described for
(A).
146 JING ET AL.five Ad promoters (Fig. 7B). The greatest suppression
was observed for the E4 and E2 promoters. Rep78 ap-
parently responds to E1a in different ways depending on
the Ad transcription promoter in question. For the E1b
and E3 promoters, there is less luciferase activity in the
presence of Rep78 when E1a is also present, suggesting
that E1a causes Rep78 to become a suppressor,
whereas Rep78 prevents E1a-mediated trans-activation
of the E1a, E2, and E4 promoters.
DISCUSSION
In this study we report on an analysis of AAV interac-
tions with adenovirus. In the coinfected cell, AAV utilizes
Ad proteins and RNA to efficiently express its genome
and replicate itself. However this Ad benevolence comes
at a price for the helper in terms of limited Ad replication.
Here we report that the Ad infectious cycle is delayed in
the presence of an AAV coinfection. The delay is mani-
fest in a prolonged survival of the host cell. The delay is
not realized with UV-inactivated AAV, suggesting that it is
not the virion that causes the delay even though UV-AAV
binds to the virus receptor. Expression of the Ad E3 death
protein is required for the efficient lysis of Ad-infected
cells and mediates the release of Ad from cells after the
infectious cycle is complete (Tollefson et al., 1996a,b).
Rep78-mediated suppression of E1a-mediated transacti-
vation of the E3 promoter (Fig. 7) is a possible explana-
tion for how AAV delays Ad-mediated cell killing.
Early analyses of AAV and Ad interactions revealed
that Ad production was limited by up to 100-fold and Ad
DNA replication was limited by up to 10-fold (Carter et al.,
1979; Casto et al., 1976a,b). AAV defective interfering
particles did not display similar levels of Ad inhibition.
The mechanism of this inhibition has never been thor-
oughly studied. Our results shown here, and those from
the earlier studies, strongly suggest that expression
of AAV genes is required for inhibition of Ad DNA repli-
cation. The AAV rep gene has been shown to block viral
and cellular DNA replication in a variety of plasmid
transfection studies (Antoni et al., 1991; Hermonat, 1992;
Kleinschmidt et al., 1995; Yang et al., 1995; Weitzman et
al., 1996). Weitzman et al. (1996) were the first to dem-
onstrate that a plasmid-transfected rep gene could in-
hibit Ad DNA amplification using in situ hybridizations.
The rep gene’s suppression of viral and cellular DNA
replication is in contrast to results obtained when AAV
infects primary cultures or some cell lines (Klein-Bauer-
schmitt et al., 1992; Winocour et al., 1992). In these
assays, an inactivated AAV particle was capable of in-
ducing a G2/M phase block. Thus AAV’s inhibitory effects
on the helper virus and the host cell are due to multiple
viral elements.
AAV gene products may prevent Ad replication directly
by binding to Ad DNA or sequestering essential cellular
or viral replication factors. Alternatively, AAV may inhibitAd replication indirectly by blocking the expression of
replication-essential Ad early genes. One published re-
port indicated that transfection of a Rep-expressing plas-
mid had no apparent effect on E2a protein expression as
measured in immunofluorescent assays (Weitzman et al.,
1996). Another report indicated that AAV infection inhib-
ited E1b 55-kDa expression in an Ad-transformed ham-
ster cell line (Ostrove et al., 1981). Our results showing
suppression of E1a and E2a gene expression in AAV and
Ad-coinfected cells and suppression of E2a expression
in Ad-infected Neo6 cells are consistent with the hypoth-
esis that AAV inhibits Ad replication by inhibiting early
gene expression.
The Rep proteins suppress translation of mRNAs from
the AAV p40, cap gene, transcription promoter (Trempe
and Carter, 1988). Recently, similar effects on translation
have been obtained in in vitro assays (Takeuchi et al.,
2000). Our results in AAV and Ad-coinfected HeLa cells
and Ad-infected Neo6 cells suggest that AAV and Rep-
mediated inhibition of E2a mRNA accumulation is re-
sponsible for the diminution of E2a protein levels. Other
work from our laboratory shows that neither Rep78 nor
Rep52 affect E2a mRNA stability, suggesting that the
affect on mRNA is due to changes in transcription (S.
Nada, X.-J. Jing, and J. P. Trempe, unpublished observa-
tion). That work also demonstrates that the Rep proteins
exert posttranscriptional effects on E2a gene expression.
Although Rep proteins may also have direct effects on Ad
DNA replication, it is possible that the effects on E2a
gene expression may be sufficient for blocking Ad rep-
lication.
Each of the Ad early transcription promoters was iso-
lated and cloned into luciferase gene reporter plasmids
to determine how they are affected by a cotransfected
rep gene plasmid. Interestingly, in the absence of a
cotransfected E1a gene, Rep caused an inhibition of
expression from the E1a, E2a, and E4 plasmids but
trans-activated the E3 and E1b promoters. However in
the presence of E1a 289 a.a. protein expression, the Rep
proteins caused a decrease in expression from all five
early promoters. Thus in the presence of the E1a protein
the Rep protein becomes a promiscuous repressor of the
Ad early transcription promoters. These analyses were
limited to luciferase enzyme assays and they were not
accompanied by luc mRNA measurements. Therefore we
cannot differentiate between transcriptional and post-
transcriptional effects.
Examination of the Ad early promoters suggests pos-
sible transcription factors that may be targeted by the
Rep proteins. With the exception of E1b, all of the early
promoters contain one or more ATF/CREB binding sites
(Flint and Shenk, 1997). ATF/CREB elements are bound
by the cAMP response element binding protein that in
turn is activated by phosphorylation mediated by protein
kinase A (PKA). The AAV Rep78 and Rep52 proteins have
been shown to interact with protein kinase X (PKX), a
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quale and Stacey, 1998). Rep association with PKA re-
sults in inhibition of its ability to phosphorylate CREB,
which in turn prevents activation of ATF/CREB-containing
promoters. The pCDMRep78 plasmid used in our tran-
sient luc transfection assays expresses predominantly
the Rep78 protein. Therefore CREB inactivation may ex-
plain some of our results. However the E3 promoter,
which also has an ATF/CREB site, is activated by Rep78
in the absence of E1a. Thus Rep inhibitory effects are
more complicated than simple sequestration of protein
kinases that modify ATF/CREB. All of the Ad early pro-
moters also contain TATA, or noncanonical TATA boxes.
The CR3 domain of the E1a 289 a.a. trans-activates these
TATA elements. One group has shown that the Rep pro-
tein associates with the TATA box-binding protein, TBP
(Hermonat et al., 1998). Another group has shown that
the Rep protein disrupts TBP binding to the TATA element
(Su et al., 2000). However both E1b and E3 promoters
have TATA elements but are activated by Rep in the
absence of E1a. These data, and our evidence that Rep
is a promiscuous suppressor in the presence of the E1a
289 a.a. protein, suggest that Rep-specific interactions
may prevent E1a activation of TBP function. One possible
explanation of Rep effects in the presence of E1a is that
coexpression of these proteins is toxic to the cell (Sau-
dan et al., 2000). Mouse NIH3T3 cells begin to die within
60–72 h after they were cotransduced with retroviruses
expressing the Ad E1a gene and the AAV Rep78 protein
(Saudan et al., 2000). This report may explain our previ-
ous results in which we observed that Rep protein ex-
pression prevented E1a/ras-mediated transformation of
NIH3T3 cells (Khleif et al., 1991). Conversely, induction of
Rep expression in 293-derived Neo6 cells resulted in
cytostasis rather than cytotoxicity after 2 weeks in cul-
ture (Yang et al., 1994). The luciferase assays shown in
Fig. 7 were performed 48 h after transfection and there
were no obvious cytotoxic effects observed at this time
point. The cell killing observed in the NIH 3T3 cells was
not measured until at least 60 h after retrovirus trans-
duction; therefore, it is difficult to compare the data in
Fig. 7 with the Saudan et al. (2000) report.
The studies presented here have demonstrated that
AAV and Rep protein-mediated inhibition of Ad gene
expression plays an important role in blocking Ad repli-
cation. Given published reports of AAV virion effects on
host cells and Rep effects on mRNA translation, suppres-
sion of transcription is not the only means by which this
virus interacts with its helper viruses and host cells. The
biological significance of these inhibitory effects may be
to allow AAV to effectively compete with Ad to insure its
survival in the coinfected cell. As the biochemical mech-
anisms of Rep protein functions are unraveled, a better
understanding of this unique virus will be attained.MATERIALS AND METHODS
Cells and viruses
Ad type 2 and Ad type 5 (Ad2 and Ad5) were originally
obtained from the American Type Cell Culture (ATCC).
Neo6 and Neo5 cells were produced by stable introduc-
tion of the AAV rep gene under the control of the mouse
metallothionein transcription promoter into human 293
cells (Yang et al., 1994). Neo6 cells express Rep protein
when induced with heavy metal salts, while Neo5 cells
do not express Rep. HeLa, KB, and 293 cells were grown
in Eagle’s minimum medium (MEM) supplemented with
glutamine, penicillin (50 mg/ml), streptomycin (50 mg/ml),
and 10% fetal bovine serum. Neo6 and Neo5 cells were
grown in the same supplemented MEM, except contain-
ing 10% dialyzed fetal bovine serum and geneticin at 0.5
mg/ml. All cells were maintained as monolayer cultures
at 37°C in a 5% CO2 atmosphere.
AAV was prepared by calcium phosphate DNA trans-
fection (Ausubel et al., 1987) of the pAV2 plasmid (Laugh-
lin et al., 1983) on to 20 3 15-cm plates of 293 cells (each
containing 1–1.4 3 107 cells) that were infected with Ad5
at an m.o.i. of 5 in serum-free medium at 37°C for 1–1.5
h. Serum was added to a final concentration of 10% and
the cultures incubated at 37°C. The cultures were har-
vested 48–72 h postinfection (p.i.) and AAV was purified
by CsCl equilibrium centrifugation and titered by indirect
immunofluorescence as described (Carter et al., 1979).
Recombinant AAV expressing the Escherichia coli
b-galactosidase gene under the control of the CMV early
promoter (AAV-bgal) was prepared by calcium phos-
phate plasmid cotransfection of Ad-infected 293 cells.
pAAV/Ad (20 mg) (Samulski et al., 1989) and 5 mg
pAVbgal were cotransfected onto each of 10- and 15-cm
dishes of 293 cells that were infected with Ad5 at 5 m.o.i.
Seventy-two hours later the cells were harvested by
scraping and vector was purified using CsCl density
gradient centrifugation as described above. AAV-bgal
was titered by transduction of Ad-infected HeLa cells
followed by staining with X-gal. Recombinant AAV ex-
pressing the green fluorescent protein gene under the
control of the CMV early promoter was prepared in sim-
ilar packaging assays using the pTRUF-5 vector plasmid
(kindly provided by Dr. N. Muzyczka).
UV inactivation of AAV and recombinant AAV was per-
formed by diluting virus in serum-free medium in six-well
culture dishes. The virus was then irradiated in a UV
Stratalinker (Stratagene Model 1800) at an energy level
of 2.4 3 105 mJ/cm2. Complete inactivation of AAV was
verified by coinfection of HeLa cells with Ad and the
inactivated virus. Forty-eight hours after infection the
cultures were harvested and examined for replicative
form AAV by Southern hybridization analyses.Adenovirus was obtained by infection of 293 cells at
an m.o.i. of 5. The cultures were harvested 48–72 h later
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and Russell, 1971).
Plasmids used in this study
Plasmid pAV2 containing the entire AAV genome se-
quence cloned in pBR322 (Laughlin et al., 1983) was
used in generating wild-type AAV virus. Plasmid pCDM-
Rep78 contains the wild-type Rep gene cloned in pCDM8
(Invitrogen Inc.) under the control of CMV early promoter
(Yang and Trempe, 1993). Plasmid pCMVE1a13S ex-
presses the 289 a.a. E1a protein (White et al., 1991). The
pAAV/Ad, pAVbgal, and pTRUF-5 plasmids are described
above.
Vent DNA polymerase (New England Bio-Lab) was
used in polymerase chain reactions (PCR) to amplify
DNA fragments containing the Ad2 early transcription
promoter elements. The primer sets were created with
flanking HindIII and XhoI sites for cloning purposes.
The sizes, location in the Ad2 genome, and primers
used for each of the promoters are as follows: E1a,
532 bp, nucleotides 1–532, CTCGAGCATCATCATAAT-
ATACCTTA and AAGCTTGGAGGAGAAAACTCTACTCG;
E1b, 261 bp, nucleotides 1438–1699, CTCGAG-
TCTGGGCAACCTTGGA, and AAGCTTGAGGTCAGATG-
TAACCAAGAT; E2a, 286 bp, nucleotides 27,052–27,338,
AAGCTTAGATCAGCTTCGGCGCAC and CTCGAGATA-
TCATGTGGGGTCC; E3, 311 bp, nucleotides 27,328–
27,639, CTCGAGTCAACGGAATCCGCGCC and AAGCT-
TGGAGCTCACCGACTCGTC; E4, 360 bp, nucleotides
35,577–35,937, CTCGAGCATCATCATAATATACCTTA
and AAGCTTTCGACACGGCACCAGCTCA. Each ampli-
fied product was inserted into the pGL3-Basic luc
reporter vector (Promega Inc.) and verified by manual
DNA sequencing (Sequenase 2.0 DNA sequencing
system, U.S. Biochemicals).
Antibodies
Antibody against Ad 72-kDa DNA binding protein, a
mouse monoclonal IgG (MAb 37-3), was kindly provided
by Dr. I. Kovesdi of GenVec Inc. AAV Rep protein-specific
polyclonal antibodies were obtained from rabbits immu-
nized with a recombinant Rep protein expressed from E.
coli (Trempe et al., 1987). Antibody against Ad E1a pro-
tein, a polyclonal rabbit IgG (13S-5), was obtained from
Santa Cruz Biotechnology Inc. (Cat. No. SC-430). Alkaline
phosphatase-conjugated anti-rabbit IgG (Cat. No. 31340)
was obtained from Pierce Co.
Virus infection and induction of Neo5/6 cells
Virus infections were carried out in serum-free MEM
medium and adsorption was for 1–2 h at 37°C. The
medium was then either replaced with regular serum-
containing medium or was supplemented with serum to
a final concentration of 10%. For heavy metal ion (HM)
induction to express Rep protein in Neo5/6 cells, CdSO4and ZnCl2 were included in the culture medium at final
concentrations of 2 and 100 mM, respectively, 7–10 h
before Ad infection, and left in the medium until harvest.
Indirect AAV receptor binding assay
HeLa cells (1 3 105) were plated in 24-well dishes. The
cultures were transduced with 1 m.o.i. of AAV-bgal alone,
or along with 2 or 25 m.o.i. of AAV-gfp or UV-inactivated
AAV-gfp. One hour after adding the vector, the medium
was removed and the cell monolayer washed with phos-
phate buffered saline. Normal medium containing Ad5 at
an m.o.i. of 5 was placed on the cultures for 48 h.
Alternatively 1 mM heparin was used in place of the
AAV-gfp vector to block AAV binding to its receptor. After
48 h the cultures were harvested by scraping, lysed, and
b-galactosidase assays were performed using the
Galactostar kit (Tropix).
Cytotoxicity assays
HeLa cells (1.5 3 104 per well, approximately 10%
confluent) were plated in 24-well dishes in triplicate. The
cultures were infected with Ad5 (m.o.i. 5 5) alone or
together with AAV or UV-inactivated AAV (m.o.i. 5 400) in
200 ml of serum-free medium at 37°C for 90 min. The
inoculum was removed, replaced with fresh serum-con-
taining medium, and incubated at 37°C for the duration
of the experiment. Twenty-four hours after infection and
every 24 h thereafter, for 144 h, cells were harvested by
trypsinization to obtain single-cell suspensions and col-
lected by low-speed centrifugation. Cell pellets were
resuspended in 50–100 ml of culture medium and stained
with 0.025% trypan blue. Fifteen microliters of each cell
suspension was microscopically examined and the per-
centage of viable cells was determined.
HeLa cells (1.5 3 104 per well, approximately 10%
confluent) in phenol red-free MEM were plated in 24-well
dishes in triplicate. The cultures were infected with Ad5
and AAV or UV-inactivated AAV as described in the cy-
totoxicity section above. Twenty-four hours after infection
and every 24 h thereafter, for 144 h, MTT viability assays
were performed as described (Mossman, 1983).
Ad DNA replication assay
An amount of 1 3 106 KB or HeLa cells in 35 mm
dishes was infected with variable amounts of AAV, UV-
AAV, or recombinant AAVbgal. Five hours later the cul-
tures were infected with Ad2 at an m.o.i. of 5 or Ad5 at an
m.o.i. of 1. Forty-eight hours after Ad infection the cul-
tures were harvested and low molecular weight DNA
isolated by the method of Hirt (1967). The DNA was
digested with restriction endonuclease EcoRI and sepa-
rated by agarose gel electrophoresis. Southern transfer
and hybridization with a 32P-labeled genomic Ad probe
were used to reveal the multiple bands of the Ad genome
EcoRI fragments. Probe preparation was performed us-
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Mannheim). The blot was then exposed to X-ray film.
Densitometer analyses were performed on the X-ray
film using a Kodak Image Station 440CF and Kodak
Digital Science 1D image analysis software.
Protein extraction and immunoblot analysis
Isolation of nuclear extracts, SDS–PAGE, and immuno-
blot analysis of viral proteins were performed as de-
scribed previously (Yang et al., 1994).
Northern analysis of Ad early gene expression
Total RNA was isolated from infected cells using
TRIZOL reagent (BRL Life Technologies) according to the
manufacturer’s instructions. Total RNA (30 mg) was sep-
arated by formaldehyde agarose gel electrophoresis.
RNA was transferred to Nytran membrane (Schleicher &
Schuell) as described (Ausubel et al., 1987). RNA was
immobilized by UV cross-linking using a Stratalinker. A
RiboProbe in vitro Transcription System (Promega) was
used with cloned and linearized Ad E2a or cellular b-ac-
tin gene fragments to generate 32P-labeled ribonucleic
acid probes. The Northern blots were prehybridized, hy-
bridized, washed, and exposed to X-ray film as described
(Ausubel et al., 1987).
Plasmid transfections and luciferase reporter assays
Calcium phosphate–DNA transfection mixes were pre-
pared as described (Ausubel et al., 1987) in a 200-ml
volume containing 1 mg of promoter plasmid (pE2aluc,
pE1aluc, pE1bluc, pE4luc, and pE3luc) plus 2 mg pCDM-
Rep78 or pCDM8. Fifty microliters of the mixture was
then added to 6 3 104 HeLa cells in 24-well plates. For
E1a plasmid transfections, 200 ml calcium phosphate–
DNA transfection mixes were prepared containing 0.5 mg
of the Ad/luc plasmids, 1 mg of the Rep plasmids, and 2
mg of the pCMVE1a13S plasmids. (The E1a plasmids
were kindly provided by Dr. Eileen White.)
Forty-eight hours after transfection cell lysates were
prepared and luciferase assays performed using the
Luciferase Assay System (Promega) as described by the
manufacturer. Enzyme activity was reported after stan-
dardization of the amount of protein in the extracts.
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